Business Standard

Use of hydroxychloroquin for Covid-19 treatment banned by France govt

The decision came a day after French health organisations, namely, the HCSP health advisory and ANSM drugs agency, advised against using hydroxychloroquine for Covid-19 treatment

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
Premium

According to the study published in the British medical journal, The Lancet, the drug increases the risk of death among the ill and worsens other symptoms

ANI
France on Wednesday (local time) officially banned hydroxychloroquine as a treatment for Covid-19 after a series of medical studies revealed that the malaria drug could be harmful.

The decision came a day after French health organisations, namely, the HCSP health advisory and ANSM drugs agency, advised against using hydroxychloroquine for Covid-19 treatment, considering its negative side effects.

Moreover, the agency announced that like the World Health Organisation (WHO) did on Monday, it would also pause clinical trials with the drug amid safety measures.

"...This drug (hydroxychloroquine) should not be prescribed to patients with Covid-19," a statement published by the French Health Ministry said.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in